Skip to main content

Table 1 Clinical characteristics of patient enrolled in the study

From: High Erk-1 activation and Gadd45a expression as prognostic markers in high risk pediatric haemolymphoproliferative diseases

Variable

No. of samples

%

AGE

  

≤ 24 months

10

13.9

> 24 months

62

86.1

SEX

  

MALES

48

65.3

FEMALES

24

34.7

WBC

  

< 20000/mmc

31

43

≥ 20000/mmc

41

57

Tumour type

  

AML

45

 

   M0

1

1.4

   M1

5

7

   M2

18

25

   M4

10

13.8

   M5

8

11

   M6

1

1.4

   M7

2

2.8

ALL-Tcells

18

 

   L1

1

1.4

   L2

17

23.6

NHL

9

 

   T cells

3

4.2

   B cells

5

7

   Burkitt

1

1.4